XERS - Xeris Pharmaceuticals Inc.'s (XERS) CEO Paul Edick on Q1 2021 Results - Earnings Call Transcript
Xeris Pharmaceuticals, Inc. (XERS) Q1 2021 Earnings Conference Call May 13, 2021, 8:30 AM ET Company Participants Allison Wey - Senior Vice President, Investor Relations and Corporate Communications Paul Edick - Chairman and CEO Barry Deutsch - Chief Financial Officer Conference Call Participants Zach Sachar - Piper Sandler Daniel Busby - RBC Capital Markets Dan Clark - Mizuho Presentation Operator Good day and thank you for standing by. Welcome to the Xeris Pharmaceuticals First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded. [Operator Instructions] I would now like to hand the conference over to Allison Wey, Senior Vice President of Investor Relations and Corporate Communications. Please go ahead. Allison Wey Thank you, Laurie. Good morning. And welcome to Xeris Pharmaceuticals first quarter
For further details see:
Xeris Pharmaceuticals, Inc.'s (XERS) CEO Paul Edick on Q1 2021 Results - Earnings Call Transcript